Second line medication for Crohn's disease

RX_CROHN_2NDLINE

No definition available.

Endpoint definition

FinnGen phenotype data

429209 individuals

diagram downward connector

Apply sex-specific rule None

429209

diagram downward connector

Check conditions None

429209

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Medicine purchases: ATC L04AX|L01BB02

1 out of 7 registries used, show all original rules.

24059

diagram downward connector
diagram bullet

Check minimum number of events

Min. number of events 3

24059

diagram downward connector

Include endpoints None

24059

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

23314

diagram downward connector
RX_CROHN_2NDLINE

Control definitions

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze DF5

Summary Statistics

Key figures

All Female Male
Number of individuals 23314 14391 8923
Unadjusted prevalence (%) 5.66 6.25 4.91
Mean age at first event (years) 50.64 49.64 52.26

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.06 3.07 [2.48, 3.79] 4.6e-25 1586
15 years 0.01 2.05 [1.74, 2.41] 1.3e-17 802
5 years 0.01 3.70 [3.18, 4.29] 1.5e-65 488
1 year 0.00 3.58 [2.81, 4.57] 1.0e-24 89

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: RX_CROHN_2NDLINE – Second line medication for Crohn's disease
GWS hits: 35

Survival analyses between endpoints

Plot

before Second line medication for Crohn's disease
after Second line medication for Crohn's disease

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Second line medication for Crohn's disease

Endpoint not on priority list, no data to show.